If it is only 24 cents per share
then MYX has paid too much
.
I think there is ome thing big missing in the calculations of the analyst.
May be analysts is a non sales and marketing pharma man . When a unique product hits the market it takes it like a storm and 50-60% market share is gone and many competitors become obsolewte.
Same will happen here in 10 billion combined market in USA for E4 contraceive and HRT.
If it is only 24 cents per share then MYX has paid too much . I...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M | |||
| Open | High | Low | Value | Volume |
| $5.13 | $5.15 | $5.08 | $445.2K | 87.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 810 | $5.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.15 | 2033 | 2 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |